A new sulfonylurea called Amaryl (AM-a-ril, glimepiride)

March 1996

A new sulfonylurea called Amaryl (AM-a-ril, glimepiride) will soon hit the market. It's from Hoechst Marion Roussel...the same folks who market DiaBeta (glyburide).

Amaryl works as well as glyburide.

The company will claim that Amaryl is safer...less hypoglycemia. But the jury is still out about whether this is significant.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote